cosela
(trilaciclib)G1 Therapeutics, Inc.
Usage: COSELA is indicated to reduce the incidence of chemotherapy-induced myelosuppression in adults prior to platinum/etoposide or topotecan regimens for extensive-stage small cell lung cancer (ES-SCLC).
5 results
etopophos
(etoposide phosphate)H2-Pharma, LLCUsage: ETOPOPHOS is indicated for use in combination with other chemotherapeutic agents to treat refractory testicular tumors and, alongside cisplatin, for the first-line treatment of small cell lung cancer.etoposide
(Etoposide)Meitheal Pharmaceuticals Inc.Usage: Etoposide Injection is indicated for managing refractory testicular tumors and as a first-line treatment for small cell lung cancer, used in combination with other approved chemotherapy agents following appropriate surgical and therapeutic interventions.topotecan
(Topotecan)Accord Healthcare Inc.Usage: Topotecan Injection is indicated for treating sensitive small cell lung cancer after first-line chemotherapy failure and, in combination with cisplatin, for stage IV-B, recurrent, or persistent cervical carcinoma not suitable for curative surgery or radiation therapy.topotecan hydrochloride
(TOPOTECAN HYDROCHLORIDE)Fresenius Kabi USA, LLCUsage: Topotecan hydrochloride is indicated for treating metastatic ovarian cancer after chemotherapy progression, small cell lung cancer in platinum-sensitive patients post-first-line treatment progression, and Stage IV-B cervical cancer in combination with cisplatin, for patients not eligible for curative treatment.